These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 8607027)
1. Noninfectious gene transfer and expression systems for cancer gene therapy. Cooper MJ Semin Oncol; 1996 Feb; 23(1):172-87. PubMed ID: 8607027 [TBL] [Abstract][Full Text] [Related]
2. Targeting strategies in cancer gene therapy. Wang JH; Liu XY Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter. Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620 [TBL] [Abstract][Full Text] [Related]
4. Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review). Bauerschmitz GJ; Barker SD; Hemminki A Int J Oncol; 2002 Dec; 21(6):1161-74. PubMed ID: 12429964 [TBL] [Abstract][Full Text] [Related]
5. Gene-viral vectors: a promising way to target tumor cells and express anticancer genes simultaneously. Qian Q; Sham J; Che X; Xu J; Xue H; Cui Z; Zhu B; Wu M Chin Med J (Engl); 2002 Aug; 115(8):1213-7. PubMed ID: 12215295 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein. Zhang J; Frolov I; Russell SJ J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589 [TBL] [Abstract][Full Text] [Related]
7. Gene transfer technologies for the gene therapy of cancer. Vile R; Russell SJ Gene Ther; 1994 Mar; 1(2):88-98. PubMed ID: 7584073 [TBL] [Abstract][Full Text] [Related]
8. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis. Dorer DE; Nettelbeck DM Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy. Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695 [TBL] [Abstract][Full Text] [Related]
10. Targeted gene delivery: a two-pronged approach. Anwer K; Bailey A; Sullivan SM Crit Rev Ther Drug Carrier Syst; 2000; 17(4):377-424. PubMed ID: 10958247 [TBL] [Abstract][Full Text] [Related]
11. Reporter gene imaging: potential impact on therapy. Serganova I; Blasberg R Nucl Med Biol; 2005 Oct; 32(7):763-80. PubMed ID: 16243653 [TBL] [Abstract][Full Text] [Related]
12. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ. Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779 [TBL] [Abstract][Full Text] [Related]
13. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment. Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095 [TBL] [Abstract][Full Text] [Related]